Industry News: Cobra Biologics announces major expansion of manufacturing facilities in US and Europe

Date Published01/18/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Cobra Biologics
Parent companyCognate BioServices, Inc.
Type of work Manufacturing
If manufacturing, is the company a contract manufacturer?Yes
Reshoring category:Reshoring
Total number of jobs (added or to be added):550
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
City reshored to:Memphis
State(s) reshored to:TN
If relevant, work nearshored to:-
Product(s) reshoredliving therapeutics, viral vectors, plasmid DNA
What domestic positive factors made reshoring more attractive?Infrastructure, Lead time/Time to market, Under-utilized capacity
Find Reshoring Articles